Clever Leaves Holdings Inc. (CLVR) vs Organogenesis (ORGO)
- Clever Leaves Holdings Inc. CLVR 0.01 0.00%
- Organogenesis ORGO 0.99 −10.81%
Clever Leaves Holdings Inc. and Organogenesis are both Drug Manufacturers Specialty & Generic companies. Organogenesis is the larger, with a market value of $142.8M against $96.5M — 1.5× the size. Organogenesis grew revenue faster over the last twelve months: 6.50% against 6.14%. Organogenesis has the higher net margin (−22.2% vs −102.8%) and the higher return on invested capital (−20.0% vs −52.6%). Across the 18 metrics below, Organogenesis leads on 14 and Clever Leaves Holdings Inc. on 4.
Valuation
| Metric | CLVR | ORGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| P/E | n/m | n/m | 19.25 |
| P/S | 0.00 | 0.28 | 2.11 |
| P/B | 0.00 | 0.86 | 1.78 |
| Price to free cash flow | n/m | 6.11 | 16.14 |
| EV/EBITDA | 0.44 | n/m | 12.58 |
| EV/Sales | (0.33) | 0.21 | 2.73 |
| Earnings yield | (113,051.00%) | (85.86%) | (4.38%) |
| Free cash flow yield | (55,338.01%) | 16.36% | 0.00% |
Profitability
| Metric | CLVR | ORGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 37.64% | 70.35% | 53.94% |
| Operating margin | (89.53%) | (7.84%) | 0.00% |
| Net margin | (102.77%) | (22.23%) | 0.00% |
| Free cash flow margin | (49.82%) | 4.56% | 0.00% |
| Return on equity | (55.39%) | (53.31%) | (0.40%) |
| Return on assets | (42.95%) | (23.44%) | (3.32%) |
| Return on invested capital | (52.59%) | (19.97%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack